Geneos Wealth Management Inc. Has $189,000 Stock Holdings in Corteva, Inc. (NYSE:CTVA)

Geneos Wealth Management Inc. grew its position in Corteva, Inc. (NYSE:CTVA) by 9.3% in the 4th quarter, Holdings Channel reports. The institutional investor owned 3,311 shares of the company’s stock after purchasing an additional 281 shares during the period. Geneos Wealth Management Inc.’s holdings in Corteva were worth $189,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in the company. Capital Advisors Ltd. LLC boosted its stake in Corteva by 44.4% in the third quarter. Capital Advisors Ltd. LLC now owns 566 shares of the company’s stock valued at $33,000 after acquiring an additional 174 shares during the last quarter. First Financial Corp IN bought a new position in shares of Corteva in the 4th quarter worth $35,000. Albion Financial Group UT grew its stake in shares of Corteva by 112.6% during the fourth quarter. Albion Financial Group UT now owns 606 shares of the company’s stock worth $35,000 after purchasing an additional 321 shares during the period. Bangor Savings Bank increased its holdings in Corteva by 34.7% in the third quarter. Bangor Savings Bank now owns 935 shares of the company’s stock valued at $55,000 after purchasing an additional 241 shares during the last quarter. Finally, Northwest Investment Counselors LLC acquired a new position in Corteva in the third quarter valued at about $56,000. Institutional investors own 81.54% of the company’s stock.

Analysts Set New Price Targets

A number of analysts recently weighed in on CTVA shares. Oppenheimer reiterated an “outperform” rating and issued a $70.00 price target (up from $69.00) on shares of Corteva in a research report on Friday, November 8th. KeyCorp reduced their price target on shares of Corteva from $69.00 to $68.00 and set an “overweight” rating on the stock in a research report on Friday, January 10th. Citigroup upped their price objective on shares of Corteva from $69.00 to $74.00 and gave the company a “buy” rating in a research report on Wednesday. UBS Group reduced their target price on Corteva from $74.00 to $73.00 and set a “buy” rating on the stock in a report on Friday, January 10th. Finally, Bank of America increased their price target on Corteva from $67.00 to $69.00 and gave the stock a “buy” rating in a report on Wednesday, November 20th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and fourteen have assigned a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $66.24.

Corteva Trading Up 1.8 %

Corteva stock opened at $66.15 on Friday. The company has a market cap of $45.46 billion, a price-to-earnings ratio of 66.81, a P/E/G ratio of 1.63 and a beta of 0.77. The firm has a 50-day moving average of $59.96 and a 200-day moving average of $57.74. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.50 and a quick ratio of 0.96. Corteva, Inc. has a one year low of $45.46 and a one year high of $66.24.

Corteva Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, March 17th. Investors of record on Monday, March 3rd will be given a dividend of $0.17 per share. The ex-dividend date is Monday, March 3rd. This represents a $0.68 annualized dividend and a yield of 1.03%. Corteva’s dividend payout ratio (DPR) is presently 68.69%.

Corteva announced that its Board of Directors has initiated a share repurchase program on Tuesday, November 19th that authorizes the company to buyback $3.00 billion in outstanding shares. This buyback authorization authorizes the company to reacquire up to 7.5% of its stock through open market purchases. Stock buyback programs are often an indication that the company’s leadership believes its stock is undervalued.

Corteva Company Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.